Inflammatory Bowel Diseases

Cover image for Inflammatory Bowel Diseases

February 1998

Volume 4, Issue 1

Pages fmi–fmi, 1–78

  1. Masthead

    1. Top of page
    2. Masthead
    3. Original Contributions
    4. Special Article
    5. Clinical Trials and Therapeutics
    6. Clinical Review
    7. Basic Science Review
    8. Controversies in IBD
    9. Section Editors' Commentary
    10. Selected Summaries
    1. Masthead (page fmi)

      Version of Record online: 18 APR 2007 | DOI: 10.1002/ibd.3780040101

  2. Original Contributions

    1. Top of page
    2. Masthead
    3. Original Contributions
    4. Special Article
    5. Clinical Trials and Therapeutics
    6. Clinical Review
    7. Basic Science Review
    8. Controversies in IBD
    9. Section Editors' Commentary
    10. Selected Summaries
    1. Antiinflammatory effects of enterically coated amoxicillin-clavulanic acid in active ulcerative colitis (pages 1–5)

      Dr. F. Casellas, N. Borruel, M. Papo, F. Guarner, M. Antolín, S. Videla and J.-R. Malagelada

      Version of Record online: 18 APR 2007 | DOI: 10.1002/ibd.3780040102

    2. Quality-of-life factors in adolescent inflammatory bowel disease (pages 6–11)

      Maura MacPhee, Dr. Edward J. Hoffenberg and Andrew Feranchak

      Version of Record online: 18 APR 2007 | DOI: 10.1002/ibd.3780040103

    3. Mucin secretion in inflammatory bowel disease: Comparison of a macrophage-derived mucin secretagogue (MMS-68) to conventional secretagogues (pages 12–17)

      Dr. Kirk Sperber, Jan Shim, Munisha Mehra, Annica Lin, Italas George, Shunichiro Ogata, Lloyd Mayer and Steven Itzkowitz

      Version of Record online: 18 APR 2007 | DOI: 10.1002/ibd.3780040104

    4. The presence of anti-neutrophil antibodies reflects clinical and genetic heterogeneity within inflammatory bowel disease (pages 18–26)

      Jack Satsangi, Carol J. Landers, Ken I. Welsh, Konrad Koss, Stephan Targan and Dr. Derek P. Jewell

      Version of Record online: 18 APR 2007 | DOI: 10.1002/ibd.3780040105

    5. Severe knee pain as the single symptom of CMV infection in acute ulcerative colitis treated with cyclosporine (pages 27–28)

      Dr. Geert D'Haens, Peter Suenaert, René Westhovens and Paul Rutgeerts

      Version of Record online: 18 APR 2007 | DOI: 10.1002/ibd.3780040106

  3. Special Article

    1. Top of page
    2. Masthead
    3. Original Contributions
    4. Special Article
    5. Clinical Trials and Therapeutics
    6. Clinical Review
    7. Basic Science Review
    8. Controversies in IBD
    9. Section Editors' Commentary
    10. Selected Summaries
    1. The role of the fecal stream in Crohn's disease: An historical and analytic review (pages 29–39)

      Dr. Henry D. Janowitz, Edward C. Croen and David B. Sachar

      Version of Record online: 18 APR 2007 | DOI: 10.1002/ibd.3780040107

  4. Clinical Trials and Therapeutics

    1. Top of page
    2. Masthead
    3. Original Contributions
    4. Special Article
    5. Clinical Trials and Therapeutics
    6. Clinical Review
    7. Basic Science Review
    8. Controversies in IBD
    9. Section Editors' Commentary
    10. Selected Summaries
    1. Economic evaluation: An ethical imperative? (pages 40–44)

      Professor Cam Donaldson

      Version of Record online: 18 APR 2007 | DOI: 10.1002/ibd.3780040108

  5. Clinical Review

    1. Top of page
    2. Masthead
    3. Original Contributions
    4. Special Article
    5. Clinical Trials and Therapeutics
    6. Clinical Review
    7. Basic Science Review
    8. Controversies in IBD
    9. Section Editors' Commentary
    10. Selected Summaries
    1. Nutritional therapy in Crohn's disease (pages 45–53)

      Maria A. O'Sullivan and Prof. Colm A. O'Morain

      Version of Record online: 18 APR 2007 | DOI: 10.1002/ibd.3780040109

  6. Basic Science Review

    1. Top of page
    2. Masthead
    3. Original Contributions
    4. Special Article
    5. Clinical Trials and Therapeutics
    6. Clinical Review
    7. Basic Science Review
    8. Controversies in IBD
    9. Section Editors' Commentary
    10. Selected Summaries
    1. The central role of chemokines (chemotactic cytokines) in the immunopathogenesis of ulcerative colitis and Crohn's disease (pages 54–67)

      Dr. Richard P. MacDermott, Ian R. Sanderson and Hans-Christian Reinecker

      Version of Record online: 18 APR 2007 | DOI: 10.1002/ibd.3780040110

  7. Controversies in IBD

    1. Top of page
    2. Masthead
    3. Original Contributions
    4. Special Article
    5. Clinical Trials and Therapeutics
    6. Clinical Review
    7. Basic Science Review
    8. Controversies in IBD
    9. Section Editors' Commentary
    10. Selected Summaries
    1. How do I treat erythema nodosum, aphthous ulcerations, and pyoderma gangrenosum? (page 70)

      Dr. Stephen B. Hanauer

      Version of Record online: 18 APR 2007 | DOI: 10.1002/ibd.3780040112

    2. Treatment of pyoderma gangrenosum, erythema nodosum, and aphthous ulcerations (page 71)

      Dr. Harland S. Winter

      Version of Record online: 18 APR 2007 | DOI: 10.1002/ibd.3780040113

    3. Treatment of extraintestinal manifestations of inflammatory bowel disease (page 72)

      Dr. Richard J. Grand

      Version of Record online: 18 APR 2007 | DOI: 10.1002/ibd.3780040114

  8. Section Editors' Commentary

    1. Top of page
    2. Masthead
    3. Original Contributions
    4. Special Article
    5. Clinical Trials and Therapeutics
    6. Clinical Review
    7. Basic Science Review
    8. Controversies in IBD
    9. Section Editors' Commentary
    10. Selected Summaries
    1. Treatment of erythema nodosum, aphthous stomatitis, and pyoderma gangrenosum in patients with IBD (page 73)

      Peter A. Banks and Daniel H. Present

      Version of Record online: 18 APR 2007 | DOI: 10.1002/ibd.3780040115

  9. Selected Summaries

    1. Top of page
    2. Masthead
    3. Original Contributions
    4. Special Article
    5. Clinical Trials and Therapeutics
    6. Clinical Review
    7. Basic Science Review
    8. Controversies in IBD
    9. Section Editors' Commentary
    10. Selected Summaries
    1. Giving the eosinophil a little respect in IBD (pages 75–76)

      Philip B. Miner Jr.

      Version of Record online: 18 APR 2007 | DOI: 10.1002/ibd.3780040117

    2. Cyclo- not psychosporine (pages 76–77)

      Simon Lichtiger

      Version of Record online: 18 APR 2007 | DOI: 10.1002/ibd.3780040118

SEARCH

SEARCH BY CITATION